What is the rapid plasma reagin (RPR) test for syphilis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is the Rapid Plasma Reagin (RPR) Test for Syphilis?

The RPR test is a nontreponemal antibody blood test that detects antibodies produced in response to cellular damage from syphilis infection, serving as both a screening tool and a quantitative marker for disease activity and treatment response.

Test Characteristics and Purpose

The RPR is one of several nontreponemal tests (along with VDRL, USR, and RST) that detect reagin antibodies—not antibodies directly against Treponema pallidum, but rather antibodies against cardiolipin-lecithin-cholesterol antigens released from damaged cells during infection 1. This makes it:

  • A screening test for active syphilis infection
  • A quantitative marker reported in titers (e.g., 1:4,1:16,1:64) that correlates with disease activity
  • A monitoring tool to assess treatment response and detect reinfection

The test was developed in the 1950s-60s as a rapid alternative to VDRL that could use plasma instead of serum, making specimen collection easier 2.

Performance Characteristics by Disease Stage

Based on high-quality studies using darkfield microscopy as the gold standard 1:

Primary Syphilis

  • Sensitivity: 62-93% (varies across studies, with most showing 63-77%)
  • The test may be negative early in primary infection before antibody development
  • Sensitivity increases as the chancre matures

Secondary Syphilis

  • Sensitivity: 97-100%
  • Nearly all patients with secondary syphilis have reactive RPR
  • This is the stage with highest test sensitivity

Early Latent Syphilis

  • Sensitivity: 82-100% based on available studies 1

Specificity

  • Approximately 99.5-99.7% in screening populations 3
  • False positives can occur with autoimmune diseases, pregnancy, infections, and other conditions

Clinical Applications

Screening: The RPR serves as an initial screening test, particularly useful in high-volume settings like prenatal clinics where results can be obtained in 60-90 minutes 3. In pregnancy screening of 9,347 women, RPR showed 90.9% sensitivity and 99.6% specificity 3.

Treatment Monitoring: Quantitative titers should decline after successful treatment. However, this process is slow and variable 4:

  • Only 42% of treated patients achieved seroreversion (non-reactive result) at median 235 days post-treatment
  • HIV-positive patients, those with late latent syphilis, and those with subsequent reinfections are less likely to serorevert
  • A 4-fold decline in titer (e.g., from 1:64 to 1:16) typically indicates treatment response

Reinfection Detection: A 4-fold or greater rise in titer suggests reinfection or treatment failure.

Important Caveats and Pitfalls

⚠️ The RPR is NOT specific for syphilis—it detects antibodies to cellular damage, not the organism itself. All reactive RPR tests must be confirmed with treponemal-specific tests (TPPA, FTA-ABS, or treponemal EIA).

⚠️ Serofast state: Some patients maintain low-level reactive titers (typically ≤1:4) indefinitely after treatment despite cure. This occurs in approximately 15-25% of treated patients and makes distinguishing reinfection from prior treated infection challenging 4.

⚠️ HIV coinfection affects test performance and serologic response. HIV-positive patients may have higher initial titers, slower serologic decline, and are less likely to achieve seroreversion 4.

⚠️ Prozone phenomenon: Very high antibody concentrations in secondary syphilis can paradoxically cause false-negative results if serum is not diluted. Laboratories typically screen at multiple dilutions to avoid this.

⚠️ Finger-stick/point-of-care RPR versions show significantly lower sensitivity (69.7%) compared to standard serum RPR and are not reliable alternatives 5.

⚠️ Automated RPR platforms show lower sensitivity (52.5%) than conventional RPR card tests (86.4%) but may be useful for monitoring treatment response due to higher seroconversion rates 6.

Interpretation Algorithm

For a reactive RPR result:

  1. Confirm with treponemal test (TPPA, FTA-ABS, or treponemal EIA)
  2. If treponemal test positive: Likely true syphilis (current or past)
    • Check clinical history and prior treatment records
    • High titers (≥1:16) suggest active infection requiring treatment
    • Low titers (≤1:4) may represent treated infection or early disease
  3. If treponemal test negative: Likely false-positive RPR
    • Consider causes: pregnancy, autoimmune disease, recent vaccination, other infections

For infants born to mothers with syphilis, approximately 75% will have RPR seroreversion by 3 months of age, and 96% by 6 months 7. Persistent reactivity beyond 6 months is uncommon and associated with higher birth titers.

Related Questions

What is the appropriate treatment for a patient with a positive rapid plasma reagin (RPR) indicating syphilis?
What does a reactive rapid plasma reagin (RPR) test result indicate?
In a pregnant patient with a history of syphilis and a negative rapid plasma reagin (RPR) test early in pregnancy, how often should the RPR be repeated during pregnancy?
What is the appropriate follow‑up for a patient previously treated for syphilis with a positive rapid plasma reagin (RPR) who now has an RPR titer of 1:8 after receiving an additional 2.4 million units of benzathine penicillin G intramuscularly?
What is the recommended procedure for rapid plasma reagin (RPR) testing and subsequent management of syphilis?
Why does a patient with pneumonitis have a dry cough, and why does the cough typically resolve instead of progressing?
What cumulative intra‑ocular pressure reduction can be expected when timolol 0.5% drops twice daily, Vyzulta (latanoprostene bunod) 0.024% once daily, Zolymbus (netarsudil) 0.02% once daily, and oral acetazolamide 250–500 mg every 12 hours are used together in a patient with a baseline intra‑ocular pressure of approximately 24 mmHg?
What is the typical weekly intramuscular dose of testosterone enanthate?
Do vaccinations exacerbate the symptoms of hypersensitivity pneumonitis?
A 4-year-old male has a serum potassium of 3.28 mmol/L (normal 3.5–5.0 mmol/L). How should I correct this hypokalemia intravenously using a potassium chloride solution of 2 mEq/mL?
What conditions can fibrotic hypersensitivity pneumonitis be misdiagnosed as?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.